Skip to content

Healthcare · Topic

Oncology Care

9 articles from Healthcare practitioners

Dr. Dana Rosencranz - Cancer Survivor and Chief Medical Physicist

Dr. Dana Rosencranz - Cancer Survivor and Chief Medical Physicist

Chief Medical Physicist at Texas Oncology combines breast cancer survivor insights with expertise in AI integration and personalized cancer treatment.

Jeanine Mendes·Sep 11, 2026

MRI segmentation models can now label 80 structures, but deployment is the hard part

Open-source MRI segmentation models can segment up to 80 structures. For imaging and oncology ops, deployment is the hard part.

MarketScale Newsroom·Sep 8, 2026
Dr. Dana Rosencranz - Cancer Survivor and Chief Medical Physicist

Dr. Dana Rosencranz - Cancer Survivor and Chief Medical Physicist

Dr. Dana Rosencranz’s journey as both a chief medical physicist and a breast cancer survivor offers a unique perspective into the dual experiences of being a cancer care provider and a patient. With over 23 years of experience at Texas Oncology, a leading oncology network in the United States, Dr. R

Jeanine Mendes·Sep 3, 2026
Rasonque’s 13.2-month survival result is about to hit hospital formularies

Rasonque’s 13.2-month survival result is about to hit hospital formularies

FDA cleared Revolution Medicines’ Rasonque for metastatic pancreatic adenocarcinoma. The ops work now is pathways, genotyping, and specialty pharmacy flow.

MarketScale Newsroom·Aug 30, 2026
Sobi CEO Guido Oelkers named BioNTech's next chief executive, targeting multiple approved products by 2030

Sobi CEO Guido Oelkers named BioNTech's next chief executive, targeting multiple approved products by 2030

BioNTech taps Sobi CEO Guido Oelkers as its next chief executive, with a mandate to turn a deep oncology pipeline into multiple approved products by 2030.

MarketScale Newsroom·Aug 17, 2026
From Denial to Access: Rethinking Oncology Care Through AI, Clinical Trials, and Patient-Centered Innovation

From Denial to Access: Rethinking Oncology Care Through AI, Clinical Trials, and Patient-Centered Innovation

The rapid expansion of precision medicine, biologics, and targeted cancer therapies is transforming oncology—but it’s also overwhelming a system not built to keep pace. In the U.S., cancer drugs now account for some of the highest-cost treatments in healthcare, and with that has come a surge in prior authorization requirements and denials. Studies suggest physicians…

Payerwatch·Apr 1, 2026
Biotech Moves Smarter: IDDI Powers Data-Driven Drug Innovation

Biotech Moves Smarter: IDDI Powers Data-Driven Drug Innovation

Smaller pharma companies are accelerating drug development by leveraging advanced data analytics to streamline trials and regulatory pathways

Chip Rosales·Apr 2, 2025
Rising Cancer Diagnoses in Young Adults: Lifestyle Changes and Early Screenings can Lower Risks

Rising Cancer Diagnoses in Young Adults: Lifestyle Changes and Early Screenings can Lower Risks

Early interventions and lifestyle adjustments offer young adults a fighting chance against a disease that's striking earlier than ever before

Kevin Stevenson·Jun 7, 2024
Selecting and Finding the Best Healthcare Physicians Requires a Roadmap That Leads to Trust and Accessibility

Selecting and Finding the Best Healthcare Physicians Requires a Roadmap That Leads to Trust and Accessibility

Patients struggle to find trustworthy physicians in an oversaturated market where unnecessary procedures remain rampant

Kevin Stevenson·Aug 18, 2023
← All Healthcare articles

Follow Healthcare Insights

Get new expert content in your inbox.

Free Trial

Every article here started as someone's expertise. Yours qualifies.

This coverage is produced through MarketScale with companies across Healthcare. The same platform turns your clinicians, service-line leaders, and field engineers into the coverage buyers on this page are reading. Start a free trial and see it with your own people. For qualifying companies, no credit card, no demo required.

NPS +73 · 1,000+ creators · 38+ countries

What your free trial includes

Hands-on access to the MarketScale platform
Media requests to your crowd, remote recording, AI writing tools
No demo required. No credit card.
For qualifying companies. Company confirmation required.